GlassScriptPhysician profile
Jeffrey M Friedman
NPI 1184739500
$1,382.99
in general payments reported to CMS, 2019-2025
16 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.36 · 2020: $481 · 2021: $99.89 · 2022: $185 · 2023: $281 · 2024: $13.34 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $373.83 | 2020-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Supernus Pharmaceuticals, INC. | $370.65 | 2019-2020 | |
| Abbvie INC. | $193.79 | 2022-2025 | |
| Spr Therapeutics, INC | $122.87 | 2020-2022 | |
| Merz Pharmaceuticals, LLC | $92.50 | 2025 | Xeomin |
| Biodelivery Sciences International, INC. | $52.84 | 2019-2020 | |
| Allergan, INC. | $28.63 | 2020 | |
| Pfizer INC. | $20.20 | 2023 | |
| Janssen Pharmaceuticals, INC | $18.54 | 2021 | |
| Amgen INC. | $18.20 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $17.80 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $17.29 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.15 | 2023 | Relistor |
| C. R. Bard, INC. & Subsidiaries | $13.34 | 2024 | Bard Urinary Drainage Bag |
| Averitas Pharma INC. | $12.94 | 2023 | Qutenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.